Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
2 drugs in development
By Therapeutic Area
top 3
R&D Momentum
87/100
Pipeline Velocity
74/100
Trial Completion Rate
98/100
Pipeline Concentration
28/100
Pipeline Freshness
84/100
Strategic Signals
Activity
Last 14 days
Effect of Beeswax-Based Nipple Protector and Breast Milk on the Prevention of Nipple Problems Among Postpartum Mothers: A Randomized Controlled Trial
Classification of Upper and Lower Limb Spasticity Patterns and Their Impact on Quality of Life in Patients With Multiple Sclerosis
Investigation of the Effects of Artificial Intelligence-Generated Training Programs on Strength, Speed, and Power Parameters
The Relationship of Alexithymia With Pain and Quality of Life Scales in Chronic Pain Patients Who Underwent Spinal Cord Stimulation: A Cross-Sectional Observational Study
Clinical Outcomes of Magnesium Sulfate Use in Cervical Interlaminar Epidural Steroid Injection for Chronic Cervical Radicular Pain: A Comparative Observational Cohort Study
Assessment of Upper Extremity Proprioception in Patients With Cervical Radiculopathy
The Effect of Screen to Move Program (STEP) on Screen Use Time and Physical Activity in Preschool Children
Impact of Spinal, Epidural, and Combined Spinal Epidural Anesthesia on Quality of Recovery After Cesarean Delivery
Prevalence of Accidental Awareness Under General Anesthesia in a University Hospital
Ultrasound-Guided Interscalene Block Versus Shoulder Pericapsular Nerve Group (PENG) Block for Hemidiaphragmatic Paralysis in Elective Shoulder Surgery: A Randomized Controlled Trial
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)